These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27791446)

  • 21. Biologic Therapy Utilization in Patients With Moderate to Severe Psoriasis and Psoriatic Arthritis: An Observational Summary of Biologic Therapy Use in a Clinical Setting.
    Gulliver WP; Randell S; Gulliver S; Gregory V; Nagle S; Chambenoit O
    J Cutan Med Surg; 2018; 22(6):567-576. PubMed ID: 29952225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study.
    Carpentieri A; Pacello L; De Marco IM; Loiacono A; Picconi O; Loconsole F
    J Dermatolog Treat; 2016 Oct; 27(5):399-405. PubMed ID: 26822691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study.
    AbuHilal M; Walsh S; Shear N
    J Cutan Med Surg; 2016 Jul; 20(4):313-6. PubMed ID: 26848145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearance of psoriasis: the impact of private versus public insurance.
    Buzney CD; Peterman C; Saraiya A; Au SC; Dumont N; Mansfield R; Gottlieb AB
    J Drugs Dermatol; 2015 Feb; 14(2):119-25. PubMed ID: 25689806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice.
    Duffin KC; Yeung H; Takeshita J; Krueger GG; Robertson AD; Troxel AB; Shin DB; Van Voorhees AS; Gelfand JM
    Br J Dermatol; 2014 Mar; 170(3):672-680. PubMed ID: 24266717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals.
    Mrowietz U; Kragballe K; Reich K; Griffiths CE; Gu Y; Wang Y; Rozzo SJ
    Br J Dermatol; 2013 Feb; 168(2):374-80. PubMed ID: 22880843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing patient copayment levels for topical and systemic treatments in plaque psoriasis as a case for evidence-based, sustainable pharmaceutical policy change in Greece.
    Souliotis K; Golna C; Kani C; Litsa P
    J Med Econ; 2016 Nov; 19(11):1021-1026. PubMed ID: 27207488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
    Al-Mutairi N; Nour T
    Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication adherence among patients with psoriasis on traditional systemic and biologics treatment.
    Hambly R; Kelly A; Gilhooley E; Nic Dhonncha E; Murad A; Hughes R; Lally A; Kirby B
    Br J Dermatol; 2018 Jan; 178(1):e46-e48. PubMed ID: 28762482
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With Psoriasis.
    Prussick R; Unnebrink K; Valdecantos WC
    J Drugs Dermatol; 2015 Aug; 14(8):864-8. PubMed ID: 26267731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease severity, treatment patterns, and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: results of the CRYSTAL observational study in Central and Eastern European countries.
    Raam L; Hartmane I; Valiukevičienė S; Karamova AE; Telegdy E; Botev I; Marina D; Rubant S; Albuquerque T; Constantin MM
    Front Immunol; 2024; 15():1410540. PubMed ID: 38846952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of biologic therapies for plaque psoriasis.
    Ahn CS; Gustafson CJ; Sandoval LF; Davis SA; Feldman SR
    Am J Clin Dermatol; 2013 Aug; 14(4):315-26. PubMed ID: 23696234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
    Reich K; Mrowietz U; Radtke MA; Thaci D; Rustenbach SJ; Spehr C; Augustin M
    Arch Dermatol Res; 2015 Dec; 307(10):875-83. PubMed ID: 26358263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual metabolic burden in young psoriasis patients successfully treated with biologics.
    Merzel Šabović EK; Kraner Šumenjak T; Janić M
    Arch Dermatol Res; 2024 Sep; 316(9):647. PubMed ID: 39331218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm.
    Poizeau F; Leducq S; Fardet L; Beylot-Barry M; Chaby G; Chastagner M; Corgibet F; Gouillon L; Jouan N; Jullien D; Acher A; Amatore F; Amici JM; Aubert H; Aubin F; Beneton N; Bouilly D; Bursztejn AC; Buzenet C; Chamaillard-Pujol M; Charles J; Cottencin-Charriere AC; Duval Modeste B; Fauconneau A; Fougerousse AC; Girard C; Goujon C; Khemis A; Le Ru Y; Lepelley-Dupont C; Mahé E; Marcellin X; Nicolas C; Pallure V; Parier J; Quiles N; Stoebner PE; Tauber M; Vermersch A; Viguier M; Villani AP; Chosidow O; Guillot B;
    Ann Dermatol Venereol; 2024 Sep; 151(3):103287. PubMed ID: 39013256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
    Kojanova M; Fialova J; Cetkovska P; Gkalpakiotis S; Jircikova J; Dolezal T; Arenberger P;
    Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions.
    Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E; Kemhus M
    Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of the cost effectiveness of home-based phototherapy with narrow-band UV-B radiation compared with biological drugs for the treatment of moderate to severe psoriasis].
    Vañó-Galván S; Gárate MT; Fleta-Asín B; Hidalgo A; Fernández-Guarino M; Bermejo T; Jaén P
    Actas Dermosifiliogr; 2012 Mar; 103(2):127-37. PubMed ID: 22036021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C; Quinn S; Marshman G
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry.
    Bonomo L; Abittan BJ; Hashim PW; Karki C; Mason M; Lebwohl M
    J Drugs Dermatol; 2019 Aug; 18(8):731-740. PubMed ID: 31424705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.